{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:14:19Z","timestamp":1771056859337,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC No.82173409"],"award-info":[{"award-number":["NSFC No.82173409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["No. 2020JM-323"],"award-info":[{"award-number":["No. 2020JM-323"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project from Xijing Hospital","award":["No. XJZT24JC26"],"award-info":[{"award-number":["No. XJZT24JC26"]}]},{"name":"Research Project from Xijing Hospital","award":["No. XJZT24QN33"],"award-info":[{"award-number":["No. XJZT24QN33"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11046-026-01053-w","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:18:46Z","timestamp":1769926726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for Poor Response to Itraconazole in Onychomycosis Patients: A Prospective, Observational Study in China"],"prefix":"10.1007","volume":"191","author":[{"given":"Chang","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luming","family":"Hai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-0951","authenticated-orcid":false,"given":"Meng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"12","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/myc.12533","volume":"59","author":"S Maraki","year":"2016","unstructured":"Maraki S, Mavromanolaki VE. Epidemiology of onychomycosis in Crete, Greece: a 12-year study. Mycoses. 2016;59(12):798\u2013802.","journal-title":"Mycoses"},{"issue":"4","key":"1053_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"7\u20138","key":"1053_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11046-016-0014-7","volume":"181","author":"C Gupta","year":"2016","unstructured":"Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, et al. Genotyping and in vitro antifungal susceptibility testing of Fusarium isolates from onychomycosis in India. Mycopathologia. 2016;181(7\u20138):497\u2013504.","journal-title":"Mycopathologia"},{"issue":"10","key":"1053_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/ijd.14346","volume":"58","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, et al. Global perspectives for the management of onychomycosis. Int J Dermatol. 2019;58(10):1118\u201329.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1053_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/myc.12537","volume":"60","author":"E Dubljanin","year":"2017","unstructured":"Dubljanin E, D\u017eami\u0107 A, Vuj\u010di\u0107 I, Gruji\u010di\u0107 S\u0160, Arsenijevi\u0107 VA, Mitrovi\u0107 S, et al. Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification. Mycoses. 2017;60(1):25\u201332.","journal-title":"Mycoses"},{"issue":"6","key":"1053_CR6","first-page":"678","volume":"21","author":"P Nenoff","year":"2023","unstructured":"Nenoff P, Reinel D, Mayser P, Abeck D, Bezold G, Bosshard PP, et al. S1 guideline onychomycosis. JDDG J Dtsch Dermatol Ges. 2023;21(6):678\u201392.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"8","key":"1053_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/jdv.17240","volume":"35","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Summerbell RC, Venkataraman M, Quinlan EM. Nondermatophyte mould onychomycosis. J Eur Acad Dermatol Venereol. 2021;35(8):1628\u201341.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"1053_CR8","first-page":"1","volume":"19","author":"R Hay","year":"2005","unstructured":"Hay R. Literature review. Onychomycosis J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):1\u20137.","journal-title":"Onychomycosis J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/09546630310012109","volume":"14","author":"A Firooz","year":"2003","unstructured":"Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatol Treat. 2003;14(2):95\u20138.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"1053_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000485632","volume":"4","author":"AK Gupta","year":"2018","unstructured":"Gupta AK, Mays RR. The impact of onychomycosis on quality of life: a systematic review of the available literature. Skin Appendage Disord. 2018;4(4):208\u201316.","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"1053_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/07853890.2022.2044511","volume":"54","author":"DK Lee","year":"2022","unstructured":"Lee DK, Lipner SR. Optimal diagnosis and management of common nail disorders. Ann Med. 2022;54(1):694\u2013712.","journal-title":"Ann Med"},{"issue":"12","key":"1053_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/14740338.2023.2280137","volume":"22","author":"AK Gupta","year":"2023","unstructured":"Gupta AK, Haas-Neill S, Talukder M. The safety of oral antifungals for the treatment of onychomycosis. Expert Opin Drug Saf. 2023;22(12):1169\u201378.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1053_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/14656566.1.2.287","volume":"1","author":"GE Pi\u00e9rard","year":"2000","unstructured":"Pi\u00e9rard GE, Arrese JE, Pi\u00e9rard-Franchimont C. Itraconazole. Expert Opin Pharmacother. 2000;1(2):287\u2013304.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1053_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0190-9622(97)70074-4","volume":"37","author":"PD Doncker","year":"1997","unstructured":"Doncker PD, Gupta AK, Marynissen G, Stoffels P, Heremans A. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview. J Am Acad Dermatol. 1997;37(6):969\u201374.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1053_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/myc.12799","volume":"61","author":"L Zhang","year":"2018","unstructured":"Zhang L, Xu H, Shi Y, Yu J, Tao Y, Li X. An exploration of the optimum dosage and number of cycles of itraconazole pulse therapy for severe onychomycosis. Mycoses. 2018;61(10):736\u201342.","journal-title":"Mycoses"},{"issue":"4","key":"1053_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853\u201367.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1053_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","volume":"34","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1053_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02886448","volume":"21","author":"Z Yuechen","year":"2001","unstructured":"Yuechen Z, Yanqing W, Hui C, Zhaoru Z, Ling L, Jingsi Z. Analysis of the factors influencing the therapeutic effects of onychomycosis. Curr Med Sci. 2001;21(3):259\u201362.","journal-title":"Curr Med Sci"},{"issue":"6","key":"1053_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/archpedi.154.6.614","volume":"154","author":"PH Huang","year":"2000","unstructured":"Huang PH, Paller AS. Itraconazole pulse therapy for dermatophyte onychomycosis in children. Arch Pediatr Adolesc Med. 2000;154(6):614\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"1053_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1468-3083.2009.03487.x","volume":"24","author":"B Sigurgeirsson","year":"2010","unstructured":"Sigurgeirsson B. Prognostic factors for cure following treatment of onychomycosis. J Eur Acad Dermatol Venereol. 2010;24(6):679\u201384.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/myc.13018","volume":"63","author":"S Widaty","year":"2020","unstructured":"Widaty S, Miranda E, Bramono K, Menaldi SL, Marissa M, Oktarina C, et al. Prognostic factors influencing the treatment outcome of onychomycosis Candida. Mycoses. 2020;63(1):71\u20137.","journal-title":"Mycoses"},{"issue":"1 Suppl","key":"1053_CR22","first-page":"10","volume":"74","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Lynch LE. Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutis. 2004;74(1 Suppl):10\u20135.","journal-title":"Cutis"},{"issue":"10","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/ijd.15739","volume":"60","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Venkataraman M, Anbalagan N, Guenin EP. One size does not fit all: the need for individualized treatment based on factors that may affect the therapeutic outcome of efinaconazole 10% solution for the treatment of toenail onychomycosis. Int J Dermatol. 2021;60(10):1296\u2013302.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1053_CR24","doi-asserted-by":"publisher","first-page":"12789","DOI":"10.1038\/s41598-021-92111-4","volume":"11","author":"V Silva-Neves","year":"2021","unstructured":"Silva-Neves V, Hugo V, Alves P, Amado JC, Pais-Vieira C, Sousa F, et al. Quality of life and therapeutic regimen management in onychomycosis patients and in vitro study of antiseptic solutions. Sci Rep. 2021;11(1):12789.","journal-title":"Sci Rep"},{"issue":"1","key":"1053_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/jof8010060","volume":"8","author":"A Jazdarehee","year":"2022","unstructured":"Jazdarehee A, Malekafzali L, Lee J, Lewis R, Mukovozov I. Transmission of onychomycosis and dermatophytosis between household members: a scoping review. J Fungi (Basel). 2022;8(1):60.","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"1053_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/myc.12072","volume":"56","author":"D Milobratovi\u0107","year":"2013","unstructured":"Milobratovi\u0107 D, Jankovi\u0107 S, Vuki\u010devi\u0107 J, Marinkovi\u0107 J, Jankovi\u0107 J, Raili\u0107 Z. Quality of life in patients with toenail onychomycosis. Mycoses. 2013;56(5):543\u201351.","journal-title":"Mycoses"},{"issue":"2 Pt 1","key":"1053_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","volume":"41","author":"LA Drake","year":"1999","unstructured":"Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol. 1999;41(2 Pt 1):189\u201396.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1053_CR28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/myc.13262","volume":"64","author":"MJ Chang","year":"2021","unstructured":"Chang MJ, Qiu Y, Lipner SR. Race reporting and representation in onychomycosis clinical trials: a systematic review. Mycoses. 2021;64(8):954\u201366.","journal-title":"Mycoses"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01053-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01053-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01053-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:53:20Z","timestamp":1771055600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01053-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01053-w","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The process of obtaining ethical approval from the XiJing Hospital is under study for implementation (XJLL-KY-20232079).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"27"}}